RapidShock Post-Approval Study

NCT04014842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2756

Last updated 2024-07-23

No results posted yet for this study

Summary

Compare the performance of the Reconfirmation Analysis Mode algorithm to the performance goals recommended by the American Heart Association.

Conditions

  • Cardiac Arrest

Interventions

DEVICE

RapidShock

Use of the Reconfirmation Analysis Mode algorithm

Sponsors & Collaborators

  • Zoll Medical Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-26
Primary Completion
2023-12-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04014842 on ClinicalTrials.gov